Apixaban halved the risk for bleeding compared with rivaroxaban in the treatment of acute venous thromboembolism in the ...

Favorable safety shown in secondary prevention for acute venous thromboembolism ...

Apixaban conferred lower bleeding risk during a 3-month period compared with rivaroxaban in patients with acute venous thromboembolism, researchers reported.Despite higher medication adherence to ...

New late-breaking science from AHA 2023 sheds light on new treatments for patients with atrial fibrillation (AFib). In ARTESIA, the results of which were also published in the New England Journal of ...

It's an extremely common and effective medication used to prevent and break up blood clots and as part of a treatment protocol for atrial fibrillation (AFib). But does Eliquis have side effects? We ...

Clive Hyman was described as a "healthy" man, but after a minor fall led to his death nine days later, a coroner has warned over apixaban blood thinners. A coroner has issued an urgent warning over ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant was ...

AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback. At an ...

A CORONER has issued an urgent warning over heart medication taken by thousands of Brits following the death of an apparently healthy man. Clive Hyman, 64, had been relatively fit and healthy, ...

A brand-name drug is the original version of a medication that’s FDA-approved to treat a specific condition. Generics contain exact copies of the active ingredient in the original branded drug (an ...

The new MG IM5 has range and charging figures on paper to challenge the likes of Tesla and Hyundai, and it’s sensibly priced, too. It’s a slight pity the IM5 can’t quite replicate those numbers in the ...

A new clinical classification scheme is presented, entitled “Acute Pulmonary Embolism Clinical Categories,” with 5 categories (A-E) and subcategories, ranging from low to high risk for adverse ...